19 results
8-K
EX-99.1
ONCR
Oncorus, Inc.
10 Jan 22
Regulation FD Disclosure
8:17am
pulled from Yahoo Finance on 12/22/21
Robust supply chain is critical to the successful development of any drug candidate & is a strategic asset … & greater operational flexibility Improved control over supply chain Process development improvements can be more rapidly incorporated into GMP
8-K
EX-99.1
ONCR
Oncorus, Inc.
14 Dec 20
Oncorus Appoints Scott Canute to its Board of Directors
9:03am
manufacturing and supply chain activities for Lilly’s global operations.
Mr. Canute currently serves as a director of Flexion Therapeutics. He previously
8-K
EX-99.1
ONCR
Oncorus, Inc.
7 Dec 20
Oncorus Appoints Steve Harbin as Chief Operating Officer and Chief of Staff
9:17am
manufacturing operations, supply chain, facilities and human resources. Mr. Harbin retired from Moderna in 2019, shortly after the company’s initial
8-K
EX-99.1
ONCR
Oncorus, Inc.
10 Mar 21
Oncorus Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
7:15am
. for six years, where he was a key driver of the company’s successful growth strategy, overseeing clinical and non-clinical manufacturing operations, supply … chain, facilities and human resources. Previously Mr. Harbin served as Senior Vice President, Global Operations for France-based bioMérieux SA
10-K
v24c3qvg13d0y3
10 Mar 21
Annual report
4:12pm
DRS/A
n8s4mm556r01z4x6mrgg
20 Dec 19
Draft registration statement (amended)
12:00am
424B4
izitfm77t8x5pr
12 Feb 21
Prospectus supplement with pricing info
4:23pm
S-1
4j1l0qjw4ftgm6
11 Sep 20
IPO registration
4:49pm
DRS/A
f6ptq8 fuvy3xxi
26 Aug 20
Draft registration statement (amended)
12:00am
DRS
k7vgqt
31 Oct 19
Draft registration statement
12:00am
DRS/A
qqvxhtom23uw 0feol
29 Jul 20
Draft registration statement (amended)
12:00am
424B4
ao8t4 nua8rk
2 Oct 20
Prospectus supplement with pricing info
12:00am
DRS
he7xbz6bycpjn5ha 80i
28 Jan 21
Draft registration statement
12:00am
- Prev
- 1
- Next